This inventor holds 1 USPTO granted patent. Top assignee: Innate Tumor Immunity, Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Mansi S Shah: Innovator in NLRP3 Modulation
Introduction
Mansi S Shah is a prominent inventor based in Highland Park, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as NLRP3 modulators. Her innovative work has the potential to impact therapeutic strategies for various diseases.
Latest Patents
Mansi holds a patent for "Substituted 4-amino-1H-imidazo[4,5-c]quinoline compounds and improved methods for their preparation." This patent describes improved methods and intermediates for preparing substituted 4-amino-1H-imidazo[4,5-c]quinoline compounds, which are useful as NLRP3 modulators. She has 1 patent to her name, showcasing her expertise in this specialized area.
Career Highlights
Mansi is currently associated with Innate Tumor Immunity, Inc., where she continues to advance her research and development efforts. Her work focuses on innovative approaches to cancer treatment, leveraging her knowledge of immunology and pharmacology.
Collaborations
Mansi collaborates with talented individuals such as Sha Lou and Christopher Robert Jamison. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Mansi S Shah is a dedicated inventor whose work in NLRP3 modulation is paving the way for new therapeutic options. Her contributions to the field of pharmaceutical chemistry are noteworthy and reflect her commitment to innovation.